BIOVENTUS INC. Deferred Foreign Income Tax Expense (Benefit)
BIOVENTUS INC. (BVS) reported Deferred Foreign Income Tax Expense (Benefit) of -$95.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-03-05
- BIOVENTUS INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$95.00K.
- BIOVENTUS INC. deferred foreign income tax expense (benefit) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BIOVENTUS INC. deferred foreign income tax expense (benefit) for fiscal 2023 was $2.46M.
- BIOVENTUS INC. deferred foreign income tax expense (benefit) for fiscal 2022 was -$91.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$95.00K 10-K · filed 2026-03-05 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 | |
| 2023-12-31 | $2.46M 10-K · filed 2026-03-05 | |
| 2022-12-31 | -$91.00K 10-K · filed 2025-03-11 | -$2.85M 10-K · filed 2023-03-31 |
| 2021-12-31 | -$210.00K 10-K · filed 2024-03-12 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 | |
| 2019-12-31 | $0.00 10-K · filed 2022-03-11 |